An injection designed to tackle obesity could reduce the risk of heart attacks and strokes – regardless of how much weight they lose while on the drug, according to a new study.
Researchers looked at the effects of semaglutide – which is a prescription drug that suppresses appetite and is sold under the brand names Wegovy, Ozempic and Rybelsus.
They said the anti-obesity jabs could also benefit the cardiovascular health of millions of adults, with one researcher likening it to when statins were introduced in the 1990s.
Subscribe here: http://bit.ly/1rbfUog
For more news, analysis and features visit: www.bbc.com/news
#Ozempic #WeightLoss #BBCNews
PALERMO (ITALPRESS) – “Liberi e Forti”. Un richiamo esplicito al manifesto politico di don Luigi Sturzo e, al tempo stesso,…
PALERMO (ITALPRESS) – È stato sottoscritto un protocollo d’intesa tra CNA Sicilia, l’organizzazione di rappresentanza e tutela dell’artigianato e della…
PALERMO (ITALPRESS) – Un riconoscimento per chi ha portato alto il nome di Palermo in diversi settori, dalla cultura allo…